MacGuire Cheswick & Tuttle Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | $1.12M | Sell |
17,891
-1,650
| -8% | -$103K | 0.23% | 59 |
|
2018
Q3 | $1.51M | Sell |
19,541
-3,085
| -14% | -$238K | 0.26% | 59 |
|
2018
Q2 | $1.6M | Sell |
22,626
-1,000
| -4% | -$70.8K | 0.29% | 58 |
|
2018
Q1 | $1.78M | Sell |
23,626
-3,100
| -12% | -$234K | 0.33% | 57 |
|
2017
Q4 | $1.92M | Sell |
26,726
-6,812
| -20% | -$488K | 0.35% | 55 |
|
2017
Q3 | $2.72M | Sell |
33,538
-70,183
| -68% | -$5.69M | 0.53% | 47 |
|
2017
Q2 | $7.34M | Sell |
103,721
-16,845
| -14% | -$1.19M | 1.49% | 28 |
|
2017
Q1 | $8.19M | Sell |
120,566
-7,785
| -6% | -$529K | 1.59% | 26 |
|
2016
Q4 | $9.19M | Buy |
128,351
+775
| +0.6% | +$55.5K | 1.89% | 22 |
|
2016
Q3 | $10.1M | Sell |
127,576
-15,069
| -11% | -$1.19M | 2.26% | 18 |
|
2016
Q2 | $11.9M | Sell |
142,645
-3,380
| -2% | -$282K | 2.65% | 14 |
|
2016
Q1 | $13.4M | Sell |
146,025
-130
| -0.1% | -$11.9K | 3.12% | 11 |
|
2015
Q4 | $14.8M | Buy |
146,155
+1,365
| +0.9% | +$138K | 3.32% | 7 |
|
2015
Q3 | $14.2M | Buy |
144,790
+1,385
| +1% | +$136K | 3.48% | 6 |
|
2015
Q2 | $16.8M | Sell |
143,405
-2,902
| -2% | -$340K | 3.75% | 4 |
|
2015
Q1 | $14.4M | Sell |
146,307
-3,224
| -2% | -$316K | 3.24% | 5 |
|
2014
Q4 | $14.1M | Sell |
149,531
-3,570
| -2% | -$337K | 3.16% | 5 |
|
2014
Q3 | $16.3M | Buy |
153,101
+2,352
| +2% | +$250K | 3.8% | 3 |
|
2014
Q2 | $12.5M | Sell |
150,749
-1,770
| -1% | -$147K | 2.9% | 10 |
|
2014
Q1 | $10.8M | Buy |
152,519
+4,065
| +3% | +$288K | 2.62% | 12 |
|
2013
Q4 | $11.1M | Buy |
148,454
+1,430
| +1% | +$107K | 2.69% | 11 |
|
2013
Q3 | $9.24M | Buy |
147,024
+834
| +0.6% | +$52.4K | 2.54% | 13 |
|
2013
Q2 | $7.5M | Buy |
+146,190
| New | +$7.5M | 2.15% | 18 |
|